Results 131 to 140 of about 60,584 (224)

Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia. [PDF]

Pathol Oncol Res, 2023
Hasanova A, Asadov C, Karimova N, Shirinova A, Aliyeva G, Alimirzoyeva Z.   +5 more
europepmc   +1 more source

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib. [PDF]

Pharmaceuticals (Basel)
Hajjo R, Sabbah DA, Alhaded R, Alquabe'h A, Bardaweel SK.   +4 more
europepmc   +1 more source

The silent players: Atypical <i>BCR‑ABL </i>isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review). [PDF]

Oncol Rep
Zhou X, Li A, Kong D, Shi Y, Zhang P, Shan N.   +5 more
europepmc   +1 more source

BCR-ABL tyrosine kinase [PDF]

Science-Business eXchange, 2012
openaire   +1 more source

BCR/ABL rearrangement and leukemia phenotype [PDF]

Leukemia, 1999
SAGLIO, Giuseppe, PANE F., MARTINELLI G., GUERRASIO, Angelo   +3 more
openaire   +3 more sources

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension. [PDF]

J Pathol
Menegazzi G, Desideri D, Biagioni A, Rovida E, Dello Sbarba P, Peppicelli S.   +5 more
europepmc   +1 more source

Rare Atypical Ela3 BCR-ABL transcript in acute Lymphoblastic Leukemia: a case report. [PDF]

Afr Health Sci
Xu L, Han T, Wei S, Wang N.
europepmc   +1 more source

Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors. [PDF]

PLoS One, 2023
Wang Y, Travers RJ, Farrell A, Lu Q, Bays JL, Stepanian A, Chen C, Jaffe IZ.   +7 more
europepmc   +1 more source

BCR-ABL tyrosine kinase inhibitors associated acute kidney injury: a pharmacovigilance study based on the FAERS database with a case report. [PDF]

BMC Nephrol
Shi Y, Deng L, Zhu J, Huang Y, Zeng M, Mao H, Huang Z, Wu B.   +7 more
europepmc   +1 more source

Design, Docking Analysis, and Structure-Activity Relationship of Ferrocene-Modified Tyrosine Kinase Inhibitors: Insights into BCR-ABL Interactions. [PDF]

Molecules
Philipova I, Atanasova M, Mihaylova R, Dailova-Barzeva A, Ivanov SM, Simeonova RL, Stavrakov G.   +6 more
europepmc   +1 more source